サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1764139

細胞分離市場- 世界の産業規模、シェア、動向、機会、予測、細胞タイプ別、用途別、地域別、競合別、2020-2030年

Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cell Type, By Application, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

細胞分離市場- 世界の産業規模、シェア、動向、機会、予測、細胞タイプ別、用途別、地域別、競合別、2020-2030年
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞分離の世界市場は、2024年に34億7,000万米ドルと評価され、2030年には47億6,000万米ドルに達し、CAGR 5.62％で拡大すると予測されています。

細胞分離（混合集団から特定の細胞タイプを分離するプロセス）は、再生医療、がん研究、免疫療法、幹細胞生物学などの分野で基礎となっています。ライフサイエンス分野の進歩に伴い、高純度で生存可能な細胞への需要が高まり、細胞分離の精度、拡張性、効率を高める技術への投資が増加しています。

市場概要
予測期間 2026-2030
市場規模：2024年 34億7,000万米ドル
市場規模：2030年 47億6,000万米ドル
CAGR：2025年～2030年 5.62%
急成長セグメント ヒト細胞
最大市場 北米

成長の主な原動力は、個別化医療の採用が拡大していることです。個別化医療は、標的治療の開発のために患者固有の細胞を分離することに依存しています。このニーズは、免疫療法や細胞ベースの治療が正確な細胞選択を必要とする腫瘍学において特に顕著です。高いコストと技術的障壁が課題-特に希少な細胞やデリケートな細胞の分離-となっているが、アジア太平洋地域の新興市場は、ヘルスケア・インフラ、研究能力、医薬品製造への投資の拡大に支えられ、新たな拡大機会を生み出しています。

主な市場促進要因

ヘルスケア産業の成長

主な市場課題

細胞分離技術の高コスト

主要市場動向

細胞ベースの治療に対する需要の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界の細胞分離市場に与える影響

第5章 世界の細胞分離市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 細胞の種類別（ヒト細胞、動物細胞）
    • 用途別（生体分子分離、がん調査、幹細胞調査、体外診断、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米の細胞分離市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の細胞分離市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の細胞分離市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の細胞分離市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの細胞分離市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界の細胞分離市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 5108

The Global Cell Isolation Market was valued at USD 3.47 billion in 2024 and is projected to reach USD 4.76 billion by 2030, expanding at a CAGR of 5.62%. Cell isolation-the process of separating specific cell types from a mixed population-is fundamental in fields such as regenerative medicine, cancer research, immunotherapy, and stem cell biology. As the life sciences sector advances, the demand for high-purity and viable cells is driving increased investment in technologies that offer enhanced precision, scalability, and efficiency in cell separation.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.47 Billion
Market Size 2030USD 4.76 Billion
CAGR 2025-20305.62%
Fastest Growing SegmentHuman Cells
Largest MarketNorth America

A primary growth driver is the growing adoption of personalized medicine, which depends on isolating patient-specific cells for the development of targeted therapies. This need is particularly prominent in oncology, where immunotherapies and cell-based treatments require accurate cell selection. While high costs and technical barriers pose challenges-especially in isolating rare or delicate cell types-emerging markets in the Asia-Pacific region are creating new opportunities for expansion, supported by growing investments in healthcare infrastructure, research capabilities, and pharmaceutical manufacturing.

Key Market Drivers

Growth in Healthcare Industry

The expansion of the global healthcare industry is a central factor driving the growth of the cell isolation market. With annual revenues exceeding USD 4 trillion, healthcare is supported by key sectors such as pharmaceuticals and biotechnology, contributing nearly USD 850 billion, and medical technology and diagnostics, which account for over USD 400 billion. This industry growth-especially in emerging economies-is accelerating the adoption of advanced diagnostic and therapeutic tools, including cell-based solutions.

As hospitals, laboratories, and pharmaceutical firms increasingly invest in regenerative therapies and precision medicine, the demand for scalable and reliable cell isolation techniques is rising. Additionally, the increasing global prevalence of chronic illnesses, including cancer and autoimmune diseases, has intensified the need for targeted therapies. In 2021, noncommunicable diseases were responsible for over 43 million deaths globally, with the majority occurring prematurely in low- and middle-income countries-reinforcing the importance of cell-based technologies for future treatment protocols.

Key Market Challenges

High Cost of Cell Isolation Technologies

The high cost associated with cell isolation technologies continues to be a major limitation for broader adoption, particularly in resource-limited settings. Systems like fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) require sophisticated instruments, proprietary reagents, and specialized personnel, all contributing to significant operational costs.

These expenses present a substantial barrier for smaller laboratories, academic institutions, and biotech startups. Moreover, ongoing costs-such as maintenance, consumables, and technical support-can hinder the full utilization of cell isolation tools, especially in developing countries where funding and access to infrastructure are limited.

Key Market Trends

Increased Demand for Cell-Based Therapies

A key trend influencing the cell isolation market is the rising demand for cell-based therapies. By 2035, treatments such as CAR-T, TCR, and TIL therapies are expected to make up over 45% of clinical demand for cell therapy products. These therapies are gaining traction for their ability to address a wide array of diseases, including cancer, autoimmune conditions, and degenerative disorders.

This shift toward cell-based interventions is driving the need for robust isolation technologies that can reliably deliver high-quality, contamination-free, and functional cells. As the industry focuses more on precision medicine, the development and clinical use of cell therapies require advanced systems capable of delivering consistent and reproducible results in complex workflows.

Key Market Players

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

Report Scope

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Cell Type:

  • Human Cells
  • Animal Cells

Cell Isolation Market, By Application:

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • In Vitro Diagnostics
  • Others

Cell Isolation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations

Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Cell Isolation Market

5. Global Cell Isolation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cell Type (Human Cells, Animal Cells)
    • 5.2.2. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Cell Isolation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cell Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Isolation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cell Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Cell Isolation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cell Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Cell Isolation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cell Type
        • 6.3.3.2.2. By Application

7. Europe Cell Isolation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cell Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cell Isolation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cell Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Cell Isolation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cell Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Cell Isolation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cell Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Cell Isolation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cell Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Cell Isolation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cell Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Cell Isolation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cell Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Isolation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cell Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Cell Isolation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cell Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Cell Isolation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cell Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Cell Isolation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cell Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Cell Isolation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cell Type
        • 8.3.5.2.2. By Application

9. South America Cell Isolation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cell Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Isolation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cell Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Cell Isolation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cell Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Cell Isolation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cell Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Cell Isolation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cell Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Isolation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cell Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cell Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Cell Isolation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cell Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Cell Isolation Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Becton, Dickinson & Company
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Merck KGaA
  • 16.3. Thermo Fisher Scientific Inc.
  • 16.4. Bio-Rad Laboratories Inc.
  • 16.5. Terumo Corporation
  • 16.6. PluriSelect Life Science UG & Co. KG
  • 16.7. Danaher Corporation
  • 16.8. STEMCELL Technologies Inc.
  • 16.9. Corning Inc.
  • 16.10. Akadeum Life Sciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer